These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2755911)

  • 1. Effect of diazoxide and hydralazine on intestinal transit and blood pressure in the rat.
    Pober Z; Johnson DA; Moya-Huff FA; Maher TJ
    Pharmacol Toxicol; 1989 Jan; 64(1):51-4. PubMed ID: 2755911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic vasodilatation and renal sodium excretion: effects of hydralazine and diazoxide.
    Green TP
    Life Sci; 1984 May; 34(22):2169-76. PubMed ID: 6727558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotensive sequelae of diazoxide and hydralazine therapy.
    Romberg GP; Lordon RE
    JAMA; 1977 Sep; 238(10):1025. PubMed ID: 577939
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies in the rat on endralazine, a new antihypertensive drug structurally related to hydralazine.
    Oates HF; Stoker LM
    Clin Exp Pharmacol Physiol; 1981; 8(2):133-9. PubMed ID: 7018762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction with pyridoxal as a possible mechanism of hydralazine hypotension.
    Vidrio H
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):150-6. PubMed ID: 1688973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial muscle membrane abnormalities of hydralazine-treated spontaneously hypertensive rats.
    Kwan CY; Daniel EE
    Eur J Pharmacol; 1982 Aug; 82(3-4):187-90. PubMed ID: 7128685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP as a mediator of the relaxing action of papaverine, nitroglycerine, diazoxide and hydralazine in intestinal and vascular smooth muscle.
    Andersson R
    Acta Pharmacol Toxicol (Copenh); 1973; 32(5):321-36. PubMed ID: 4354107
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions between prazosin, clonidine and direct vasodilators in the anaesthetized rat.
    Oates HF; Stoker LM; Stokes GS
    Clin Exp Pharmacol Physiol; 1978; 5(1):85-9. PubMed ID: 639362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy.
    Xu B; Makris A; Thornton C; Ogle R; Horvath JS; Hennessy A
    J Hypertens; 2006 May; 24(5):915-22. PubMed ID: 16612254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between Candesartan and Hydralazine in the protection of penile structures in spontaneously hypertensive rats.
    Mazza ON; Angerosa M; Becher E; Toblli JE
    J Sex Med; 2006 Jul; 3(4):604-611. PubMed ID: 16839316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the effect of chronic oral administration of minoxidil and hydralazine on vascular function in spontaneously hypertensive rats.
    Greeberg S
    J Pharmacol Exp Ther; 1980 Nov; 215(2):279-86. PubMed ID: 7441494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vasodilator drugs on venous tone in conscious rats.
    D'Oyley HM; Tabrizchi R; Pang CC
    Eur J Pharmacol; 1989 Mar; 162(2):337-44. PubMed ID: 2498109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channel modulators and indomethacin-induced gastric ulceration in rats.
    Toroudi HP; Rahgozar M; Bakhtiarian A; Djahanguiri B
    Scand J Gastroenterol; 1999 Oct; 34(10):962-6. PubMed ID: 10563664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension.
    Smeda JS; Lee RM; Forrest JB
    Circ Res; 1988 Sep; 63(3):534-42. PubMed ID: 3409485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the hypotensive action of prazosin.
    Oates HF; Graham RM; Stokes GS
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):41-8. PubMed ID: 901072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity studies with diazoxide, reserpine, guanethidine, and combinations of diazoxide and propranolol in dogs.
    Balazs T; Herman EH; Earl FL; Wolff FW
    Toxicol Appl Pharmacol; 1975 Sep; 33(3):498-504. PubMed ID: 1188947
    [No Abstract]   [Full Text] [Related]  

  • 17. Protective effects of hydralazine in a renal ischemia model in the rat.
    Vergona RA; Agnello A; Hirkaler G; Urbano S; Rosenberger L
    Life Sci; 1987 Aug; 41(5):563-9. PubMed ID: 3600194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal by hypothermia of vasodilator-induced tachycardia in anesthetized rats.
    Vidrio H; García-Márquez F
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):217-28. PubMed ID: 3675083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic characterization of pinacidil in rats. Comparison with hydralazine.
    Thoolen MJ; Van Meel JC; Wilffert B; Timmermans PB; van Zwieten PA
    Pharmacology; 1983; 27(5):245-54. PubMed ID: 6318232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.